Stocks

The table gives an overview of all stocks, alphabetically sorted.
 A-Mark Precious Metals, Inc. AMRK Jan 19, 2018 13.84 +0.65   
 A. Schulman SHLM Jan 19, 2018 39.15 +2.35   
 Aaon Inc AAON Jan 19, 2018 37.30 +3.32   
 Abaxis Inc ABAX Jan 19, 2018 61.16 +0.58   
 Abeona Therapeutics Inc. ABEOW Jan 19, 2018 9.55 -4.02   
 Abeona Therapeutics Inc. ABEO Jan 19, 2018 14.60 +0.34   
 Ability Inc. ABIL Jan 19, 2018 0.49 0.00   
 Abiomed ABMD Jan 19, 2018 228.29 +1.06   
 Abraxas Petroleum Corp AXAS Jan 19, 2018 2.54 -0.39   
 AC Immune SA ACIU Jan 19, 2018 13.14 +0.61   
 Acacia Communications, Inc. ACIA Jan 19, 2018 36.80 -0.57   
 Acacia Research Corp ACTG Jan 19, 2018 3.80 +1.33   
 Acadia Healthcare Company Inc ACHC Jan 19, 2018 34.01 +2.38   
 Acadia Pharmaceuticals Inc ACAD Jan 19, 2018 26.92 -3.10   
 Acasti Pharma Inc ACST Jan 19, 2018 1.02 +2.00   
 Accelerate Diagnostics Inc AXDX Jan 19, 2018 28.25 +1.44   
 Acceleron Pharma Inc XLRN Jan 19, 2018 43.04 +1.63   
 Access National Corp ANCX Jan 19, 2018 29.27 +1.28   
 Accuray Incorporated ARAY Jan 19, 2018 5.30 -0.93   
 Acelrx Pharmaceuticals ACRX Jan 19, 2018 2.05 +1.23   
 Aceto Corp ACET Jan 19, 2018 11.16 +1.00   
 Achaogen, Inc. AKAO Jan 19, 2018 11.54 -0.43   
 Achillion Pharmaceuticals ACHN Jan 19, 2018 2.99 +1.36   
 Aci Worldwide ACIW Jan 19, 2018 23.21 +2.25   
 Aclaris Therapeutics, Inc. ACRS Jan 19, 2018 24.40 +0.58   
 Acnb Corp ACNB Jan 19, 2018 30.45 +0.33   
 Acorda Therapeutics ACOR Jan 19, 2018 27.20 +8.80   
 Acorn Energy ACFN Jan 19, 2018 0.21 0.00   
 Active Alts Contrarian ETF SQZZ Jan 19, 2018 26.38 0.00   
 Activision Blizzard Inc ATVI Jan 19, 2018 70.57 +1.10   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here www.investtech.com/disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here www.investtech.com/disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
Free Trial Now